Literature DB >> 1606733

Effect of lymphocytic infiltration on the blood-retinal barrier in experimental autoimmune uveoretinitis.

S Lightman1, J Greenwood.   

Abstract

Using an experimental model of autoimmune uveoretinitis, we have examined the relationship of T cell infiltration in the retina to blood-retinal barrier (BRB) breakdown. Sensitive quantitative in vivo techniques were used to examine BRB permeability to sucrose, a low mol. wt non-transported solute. Electron microscopy was also used to localize extravasated horseradish peroxidase, a macromolecular visual tracer, from the retinal vasculature and to identify the route by which any leakage was occurring. No increase in BRB permeability was found prior to lymphocytic infiltration. By day 10 of the disease inflammatory cells could be seen within the structurally intact retina, which was shortly followed by an increase in the permeability of the BRB to sucrose. Only later in the disease process, when damage to the photoreceptor layer became apparent, did extravasation of the macromolecule HRP occur. At no stage of the disease process was there any detectable damage to inter-endothelial tight junctions. The size-dependancy of tracer extravasation in the initial stages of the disease is indicative of a paracellular route being responsible for the increase in BRB permeability. In later stages of the disease some evidence of horseradish peroxidase filled 'vesicle-like' profiles was observed. We suggest that the devastating complication of BRB breakdown in ocular inflammation is a direct consequence of lymphocytic infiltration.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1606733      PMCID: PMC1554517          DOI: 10.1111/j.1365-2249.1992.tb06474.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  33 in total

1.  Multifocal posterior uveitis: clinical and pathological findings.

Authors:  D G Charteris; W R Lee
Journal:  Br J Ophthalmol       Date:  1990-11       Impact factor: 4.638

2.  Mechanisms of edema formation in experimental autoimmune encephalomyelitis. The contribution of inflammatory cells.

Authors:  L Claudio; Y Kress; J Factor; C F Brosnan
Journal:  Am J Pathol       Date:  1990-11       Impact factor: 4.307

Review 3.  Mechanisms of blood-brain barrier breakdown.

Authors:  J Greenwood
Journal:  Neuroradiology       Date:  1991       Impact factor: 2.804

4.  Ultrastructural pathology of the 'barrier sites' in experimental autoimmune uveitis and experimental autoimmune pinealitis.

Authors:  H S Dua; A McKinnon; P G McMenamin; J V Forrester
Journal:  Br J Ophthalmol       Date:  1991-07       Impact factor: 4.638

5.  Interferon-gamma (IFN-gamma) production in vivo in experimental autoimmune uveoretinitis.

Authors:  D G Charteris; S L Lightman
Journal:  Immunology       Date:  1992-03       Impact factor: 7.397

6.  Quantitative assessment of the permeability of the rat blood-retinal barrier to small water-soluble non-electrolytes.

Authors:  S L Lightman; A G Palestine; S I Rapoport; E Rechthand
Journal:  J Physiol       Date:  1987-08       Impact factor: 5.182

Review 7.  Migration of hematogenous cells through the blood-brain barrier and the initiation of CNS inflammation.

Authors:  W F Hickey
Journal:  Brain Pathol       Date:  1991-01       Impact factor: 6.508

8.  Ultrastructural and ultracytochemical studies on the blood-brain barrier in chronic relapsing experimental allergic encephalomyelitis.

Authors:  S Kato; H Nakamura
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

9.  Homing to central nervous system vasculature by antigen-specific lymphocytes. II. Lymphocyte/endothelial cell adhesion during the initial stages of autoimmune demyelination.

Authors:  C S Raine; B Cannella; A M Duijvestijn; A H Cross
Journal:  Lab Invest       Date:  1990-10       Impact factor: 5.662

10.  A quantitative assay for experimental allergic encephalomyelitis in the rat based on permeability of spinal cords to 125I-human gamma-globulin.

Authors:  W Stohl; M S Kaplan; N K Gonatas
Journal:  J Immunol       Date:  1979-03       Impact factor: 5.422

View more
  7 in total

1.  The matrix metalloproteinase inhibitor BB-1101 prevents experimental autoimmune uveoretinitis (EAU).

Authors:  G R Wallace; R A Whiston; M R Stanford; G M Wells; A J Gearing; J M Clements
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

Review 2.  The inner blood-retinal barrier: Cellular basis and development.

Authors:  Mónica Díaz-Coránguez; Carla Ramos; David A Antonetti
Journal:  Vision Res       Date:  2017-06-27       Impact factor: 1.886

3.  Incidence of visual improvement in uveitis cases with visual impairment caused by macular edema.

Authors:  Marc H Levin; Maxwell Pistilli; Ebenezer Daniel; Sapna S Gangaputra; Robert B Nussenblatt; James T Rosenbaum; Eric B Suhler; Jennifer E Thorne; C Stephen Foster; Douglas A Jabs; Grace A Levy-Clarke; John H Kempen
Journal:  Ophthalmology       Date:  2013-12-12       Impact factor: 12.079

4.  In vivo lymphokine production in experimental autoimmune uveoretinitis.

Authors:  D G Charteris; S L Lightman
Journal:  Immunology       Date:  1993-03       Impact factor: 7.397

5.  Cystoid macular edema.

Authors:  Tryfon G Rotsos; Marilita M Moschos
Journal:  Clin Ophthalmol       Date:  2008-12

6.  METTL3 inhibits inflammation of retinal pigment epithelium cells by regulating NR2F1 in an m6A-dependent manner.

Authors:  Jiayu Meng; Xianyang Liu; Shiyun Tang; Yusen Liu; Chenyang Zhao; Qian Zhou; Na Li; Shengping Hou
Journal:  Front Immunol       Date:  2022-07-21       Impact factor: 8.786

Review 7.  Settings and mechanisms for trans-cellular diapedesis.

Authors:  Peter T Sage; Christopher V Carman
Journal:  Front Biosci (Landmark Ed)       Date:  2009-06-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.